Ritlecitinib for treating severe alopecia areata in people 12 years and over

Supporting evidence

• Evaluation report

• Draft guidance committee papers (PDF 9.01 MB)

  Published:

  27 March 2024

• Final draft guidance committee papers (PDF 2.9 MB)

  Published:

  27 March 2024